Skip to NavigationSkip to content

News

Akcea Therapeutics and Ionis Pharmaceuticals have announced that their investigational therapy Waylivra has been recommended by the EMA’s CHMP for...
Novartis is planning to offer employees 14 weeks of parental leave, a move which would make the firm one of the most generous in Switzerland.
A man in Britain has become the second person to be ‘cured’ of HIV, after receiving a bone marrow transplant from a donor with natural resistance...
New data has been revealed in support of Novartis’ Cosentyx (secukinumab) in the treatment of moderate-to-severe plaque psoriasis, demonstrating...
OxyContin drugmaker Purdue Pharma is exploring the option of filing for bankruptcy. The news comes as the Connecticut-based firm faces thousands of...
AbbVie’s interleukin-23 (IL-23) inhibitor Skyrizi (risankizumab) has secured recommendation from the EMA’s Committee for Medicinal Products for...
As part of an effort to promote low cost medicines the Indian government has announced plans to colour code generic drugs.
Canadian physicians have called on the federal government to review its funding for a programme which sends volunteer homeopaths to Honduras.
Biogen has announced it has inked an agreement to acquire clinical-stage gene therapy firm Nightstar for a total value of $800 million, which...
The head of NHS England has warned that ‘vaccination deniers’ are increasing their influence on social media through ’fake news’.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches